A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

NCT06309992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Non-Alcoholic SteatoHepatitis (NASH)

Interventions

COMBINATION_PRODUCT: Survodutide
COMBINATION_PRODUCT: Placebo

Sponsor

Boehringer Ingelheim